MD2872G2 - Metodă de pronostic al riscului apariţiei hiperplaziei dishormonale a glandei mamare - Google Patents
Metodă de pronostic al riscului apariţiei hiperplaziei dishormonale a glandei mamareInfo
- Publication number
- MD2872G2 MD2872G2 MDA20050062A MD20050062A MD2872G2 MD 2872 G2 MD2872 G2 MD 2872G2 MD A20050062 A MDA20050062 A MD A20050062A MD 20050062 A MD20050062 A MD 20050062A MD 2872 G2 MD2872 G2 MD 2872G2
- Authority
- MD
- Moldova
- Prior art keywords
- risk
- hyperplasia
- appearance
- dyshormonal
- mammary
- Prior art date
Links
Abstract
Invenţia se referă la medicină, în special la ginecologie şi poate fi utilizată pentru pronosticarea riscului apariţiei hiperplaziei dishormonale a glandei mamare la pacientele cu maladii ginecologice şi neginecologice asociate.Esenţa invenţiei constă în aceea că se recoltează sânge de la pacientă, se separă plasma sanguină, se determină concentraţia enterolactonei în ea şi, dacă aceasta este de 13…30 nmol/L, se prognozează un risc major de apariţie a hiperplaziei dishormonale, dacă de 30…70 nmol/L un risc mediu şi 70…118 nmol/L un risc minor de apariţie a hiperplaziei dishormonale a glandei mamare.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MDA20050062A MD2872G2 (ro) | 2005-03-04 | 2005-03-04 | Metodă de pronostic al riscului apariţiei hiperplaziei dishormonale a glandei mamare |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MDA20050062A MD2872G2 (ro) | 2005-03-04 | 2005-03-04 | Metodă de pronostic al riscului apariţiei hiperplaziei dishormonale a glandei mamare |
Publications (2)
Publication Number | Publication Date |
---|---|
MD2872F1 MD2872F1 (ro) | 2005-10-31 |
MD2872G2 true MD2872G2 (ro) | 2006-05-31 |
Family
ID=35229985
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MDA20050062A MD2872G2 (ro) | 2005-03-04 | 2005-03-04 | Metodă de pronostic al riscului apariţiei hiperplaziei dishormonale a glandei mamare |
Country Status (1)
Country | Link |
---|---|
MD (1) | MD2872G2 (ro) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MD1119Z (ro) * | 2016-05-06 | 2017-09-30 | Оксана ОДОБЕСКУ | Metodă de pronosticare a riscului de malignizare a tumorii filoide a glandei mamare |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MD890Z (ro) * | 2014-05-30 | 2015-10-31 | Симона КЯБУРУ | Metodă de pronostic al riscului dezvoltării hiperplaziei dishormonale a glandei mamare |
-
2005
- 2005-03-04 MD MDA20050062A patent/MD2872G2/ro not_active IP Right Cessation
Non-Patent Citations (1)
Title |
---|
Pietinen P., Stumpf K., et al. Serum enterolactone and risk of breast cancer, A case-control study in eastern Finland. Cancer Epidemiology, Bomarkers& Prevention, 2001, p. 10, 339-344 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MD1119Z (ro) * | 2016-05-06 | 2017-09-30 | Оксана ОДОБЕСКУ | Metodă de pronosticare a riscului de malignizare a tumorii filoide a glandei mamare |
Also Published As
Publication number | Publication date |
---|---|
MD2872F1 (ro) | 2005-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL291162A (en) | Isolated human rpe cells and their use for the treatment of retinal degenerative diseases | |
HK1069316A1 (en) | Hmgb1 protein inhibitors and/or antagonists for the treatment of vascular diseases | |
ES2249490T3 (es) | Articulos quirurgicos. | |
WO2003096990A3 (en) | Protein cages for the delivery of medical imaging and therapy | |
NO20044039L (no) | Konjugatorer av terapeutiske eller cytotoksiske midler og biologisk aktive peptider. | |
ATE432677T1 (de) | Gerät zur ablage von geflochtenen prothesen | |
WO2005097219A3 (en) | Ecm-based graft material | |
ATE539701T1 (de) | Zusammengesetzte schlinge zur behandlung von inkontinenz | |
WO2008045228A3 (en) | Medical devices having porous regions for controlled therapeutic agent exposure or delivery | |
TW200505881A (en) | Tri(cyclo) substituted amide compounds | |
SG171648A1 (en) | Use of dpp-iv inhibitors | |
SG10201503235VA (en) | Inhibitors Of Bruton`s Tyrosine Kinase | |
HK1096392A1 (en) | Substituted heterocycles | |
HK1109070A1 (en) | Treatment articles capable of conforming to an underlying shape | |
WO2005043967A8 (en) | Z-axis assembly of medical device programmer | |
HUP0303917A2 (hu) | Szterin abszorpció inhibitor(ok) kombinációi vérmódosítókkal és ezek alkalmazása vaszkuláris kondíciók kezelésére | |
TW200642682A (en) | A combination of medical drugs to augment the anti-cancer effect of chemotherapy | |
WO2005072277A3 (en) | Amidated parathyroid hormone fragments and uses thereof | |
WO2006027693A3 (en) | Tumor specific genes and variant RNAS and uses thereof as targets for cancer therapy and diagnosis | |
WO2004031129A3 (en) | Compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection | |
NO20053903L (no) | Nukleotidlipidesterderivater. | |
PL1869185T3 (pl) | Koniugat zawierający białko P21 do leczenia raka | |
MD2872G2 (ro) | Metodă de pronostic al riscului apariţiei hiperplaziei dishormonale a glandei mamare | |
WO2007118077A3 (en) | Mycobacterial catalase-peroxidase in the diagnosis and treatment of sarcoidosis | |
EP1370697A4 (en) | PEROXYREDOXIN-BASED MEDICINAL PRODUCTS FOR THE TREATMENT OF HIV-1 INFECTIONS AND METHODS OF USE |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG4A | Patent for invention issued | ||
KA4A | Patent for invention lapsed due to non-payment of fees (with right of restoration) | ||
MM4A | Patent for invention definitely lapsed due to non-payment of fees |